The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adu…

Eye DiseasesRetinal DiseaseGlaucoma+1 more

~Estimated

~$10 – $6,250

Duke UniversityNCT06841575

Phase 2

A Multicenter, Extension Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

The overall study objective is to continue to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of linsitinib in subjects who were enrolled i…

Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more

~Estimated

~$10 – $8,750

Sling Therapeutics, Inc.NCT06112340

← PreviousPage 2 of 2Next →